• Glenmark Receives ANDA Approval for Indomethacin americanpharmaceuticalreview
    June 29, 2017
    Glenmark Pharmaceuticals has been granted final Abbreviated New Drug Application (ANDA) approval by the United States Food & Drug Administration (U.S. FDA) for Indomethacin Extended-Release Capsules USP, 75 mg,
PharmaSources Customer Service